GrokStyle, Inc.

GrokStyle is a Cornell startup founded on home owners’ and consumers’ interest in visualizing ideas for interior design. By using a distance metrics for visual search, GrokStyle aims to provide interior design enthusiasts with an automated tool for design suggestions and ideas. GrokStyle was acquired by Facebook, Inc. in 2019.

VitaMe Technologies, Inc.

VitaMe Technologies (DBA VitaScan™) has developed a smartphone based diagnostic platform enabling accurate, fast, convenient, and low cost testing of vitamins and micronutrients in the home and at local pharmacies and clinics. The company received $1.15 million of grant funding from the United States Department of Defense in 2020.

Computational Textiles

Computational Textiles, Inc is a small employee-owned company founded to create textile visualization and manufacturing software. The company’s first product, Weft, is a web application and manufacturing process that enables anyone to transform design ideas into intricately patterned woven cloth.

AffyImmune Therapeutics

AffyImmune is an immuno-oncology company that develops T cell products for cancer therapy. The company was founded based on intellectual property generated from Weill Cornell Medicine that enables imaging of T cells in patients and T cells to specifically target tumors. The company has two products in the pipeline, and are ready to commence clinical trials in 2018

Ecolectro, Inc.

Ecolectro develops structurally robust and highly conductive polymer membranes for a range of applications, including electrolysis and fuel cell systems that not only improve performance but also dramatically decrease costs.

CycloPure, Inc.

CycloPure is engaged in the design, development, and commercialization of a new class of highly adsorbent materials for use in the separation and removal of pollutants, VOCs, and other organic compounds from water and air. The technology was partly developed by the Helbling Research Group at The School of Civil and Environmental Engineering. CycloPure has raised $8.81M in funding to date.

Fesarius Therapeutics, Inc.

Fesarius Therapeutics is developing engineered tissue scaffold products for the skin and dermal layers. The products are based off the patent-pending microstructure-containing gel scaffold technology developed at Cornell. The acellular skin replacement will aim to benefit those with wounds resulting from burns, plastic surgery, tumor removal, and other forms of trauma. The company joined the National Institutes of Health as part of its I-Corps @ NIH Winter 2020 Program in February 2020.

XyloCor Therapeutics, Inc.

XyloCor is a clinical-stage biotechnology company dedicated to developing first-in-class gene therapies for patients with cardiovascular disease. The company’s lead product comprises the use of vascular endothelial growth factor for the treatment of diffuse coronary artery disease.

Conamix, Inc.

Conamix is commercializing high performance battery materials based on proprietary Cornell technology. The company’s unique battery materials allow higher energy density in existing lithium ion architectures and are manufactured using low cost and highly commercial methods.

Embark Veterinary, Inc.

Embark is a veterinary science-focused company specializing in canine genetics. Through the use of cutting-edge genetic testing and analysis, Embark offers 21st century pet wellness advice coupled with comprehensive ancestry, morphological trait, and genetic disease information for dog owners.